Pricing Log in Create free account

ImageneBio, Inc. (IMA) vs Pliant Therapeutics, Inc. (PLRX)

ImageneBio, Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. ImageneBio, Inc. and Pliant Therapeutics, Inc. are of similar size ($50.5M and $47.3M). Pliant Therapeutics, Inc. grew revenue faster over the last twelve months: −49.0% against −68.0%. Across the 13 metrics below, Pliant Therapeutics, Inc. leads on 7 and ImageneBio, Inc. on 6.

Valuation

Metric IMA PLRX Biotechnology median
P/E n/m n/m 10.60
P/S 10.81 9.98 9.40
P/B 0.47 0.34 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.81 0.66
EV/Sales 2.71 (15.42) 9.02
Earnings yield (136.60%) (183.95%) (32.88%)
Free cash flow yield (77.70%) (140.81%) (23.13%)

Profitability

Metric IMA PLRX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.34%) (50.29%) (51.96%)
Return on assets (38.34%) (37.69%) (46.06%)
Return on invested capital (622.37%) 0.00% 0.00%

Growth

Metric IMA PLRX Biotechnology median
Revenue growth (TTM) (67.95%) (48.95%) 6.76%
EPS growth (last fiscal year) 56.38% 29.97% 29.88%
Revenue growth, 5-year CAGR (38.64%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMA PLRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.47 9.90 4.97
Net debt to EBITDA 2.85 1.27 1.01

Dividend

Metric IMA PLRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMA PLRX Biotechnology median
Market cap 47.28m 50.52m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack